Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,212
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,841
Class I recallsReasonable probability of serious health consequences
24,366
Class II recallsTemporary or medically reversible health consequences
2,892
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,073 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,714 recalls have been announced year to date.
  • Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (297).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2

Showing 19,801–19,820 of 20,558 recalls

FDA Recall Terminated Historical recordClass II

Dallergy TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Laser Pharmaceuticals, LLC, Greenville, SC 29615, NDC 16477-160-01

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

NoHist TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Distributed by: Larken Laboratories, Inc., Canton, MS 39046, NDC 68047-173-01

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

ED A-HIST TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Edwards Pharmaceuticals Inc., Ripley, MS 38663, NDC 0485-0154-01

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

Ryddex G Tablets, Decongestant, Expectorant, 100 count bottle, OTC, Centurion Labs, LLC 657 Hwy 40 South, Ste B, Richland, MS 39218, NDC 23359-024-10

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 40PSE/400GFN, 100 tablet bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0408-01

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 40PSE/400GFN/20DM, Cough Suppressant, Expectorant, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0409-01

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 3BRM/30DM/50PSE, Antihistamine, Cough Suppressant, Nasal Decongestant, Berry Vanilla Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0229-16

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 3BRM/15DM/30PSE, Antihistamine, Cough Suppressant, Nasal Decongestant, Berry Vanilla Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0230-16.

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 2CPM/15DM/5PEH, Antihistamine, Nasal Decongestant, Fruit Candy Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0228-16.

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 25CPD/200GFN, Antitussive, Expectorant, Berry Vanilla Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0221-16.

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 12.5 CPD/120GFN/5PEH, Cough Suppressant, Expectorant, Nasal Decongestant, Berry Vanilla Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0224-16

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 12.5 CPD/100GFN/30PSE, Antitussive, Expectorant, Nasal Decongestant, Raspberry Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0223-16

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 25DPH/7.5PEH, Antihistamine, Nasal Decongestant, Fruit Candy Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0226-16

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 20DM100GFN10PEH, Antitussive, Expectorant, Nasal Decongestant, Grape Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0200-16

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

AMBI 15DM/100GFN/5PEH, Antitussive, Expectorant, Nasal Decongestant, Grape Flavor, 4 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0200-04

by TG United, Inc.

Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Published
June 12, 2013
Distribution
FL, MS, SC, LA and TX

View recall →

FDA Recall Terminated Historical recordClass II

DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-32

by Hospira Inc.

Reason
Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.
Published
June 12, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-3213-12

by Hospira Inc.

Reason
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Published
June 12, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India

by Mylan Pharmaceuticals Inc.

Reason
Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..
Published
June 5, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

by Aurobindo Pharma USA Inc

Reason
Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
Published
June 5, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Camrese(TM) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg and Ethinyl Estradiol 0.01 Tablets, 2 Extended-Cycle Tablet Dispensers (NDC 0093-3134-82) and 1 Extended-Cycle Tablet Dispenser NDC 0093-3134-91), 91 Tablets Each, Rx only, TEVA Womens Health Inc., Subsidiary of TEVA Pharmaceuticals, Inc., Sellersville, PA

by Teva Pharmaceuticals USA, Inc.

Reason
Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing
Published
June 5, 2013
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.